Lonza would add drug delivery tech through Catalent merger, analyst
Lonza acquiring Catalent would make “strategic sense,” according to an analyst as rumours circulate about a CMO megamerger.
Archives for April 13, 2016
update
Trade secret laws adopted by MEPs create legal uncertainty for pharma whistleblowers says HAI
Trade secret laws adopted by the European Parliament mean employees who raise concerns about drug safety and efficacy face legal uncertainty says HAI.